Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Jun;40(3):1096–1103. doi: 10.1128/iai.40.3.1096-1103.1983

Comparison of the immunogenicity of vaccines prepared from viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, and a mixture of the two for normal and M. leprae-tolerant mice.

C C Shepard, R M van Landingham, L L Walker, S Z Ye
PMCID: PMC348163  PMID: 6343239

Abstract

Intradermal vaccines consisting of viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, or mixtures of the two were titrated in mice in doses of 10(5.2), 10(5.8), 10(6.4), 10(7.0), and 10(7.6) acid-fast bacilli. The immune response was measured by sensitization (48 to 72 h foot pad enlargement on challenge with 10(7.0) heat-killed M. leprae) and by protection against infection with a viable M. leprae challenge. There was increasing response with increasing dose of vaccine, and overall the responses to the three vaccines were similar. At the lowest dose, however, the combination of BCG and M. leprae gave superior protection. The local reaction to the vaccines in the lower dose range was less severe with the M. leprae vaccine. In another experiment, the three vaccines were compared in normal mice and in mice that had been rendered tolerant by intravenous injection of M. leprae. The tolerant mice developed no measurable sensitization on vaccination with M. leprae, but they developed partial but distinct sensitization on vaccination with BCG, alone or in combination with M. leprae. The tolerant mice developed little or no protection with any of the vaccines, however.

Full text

PDF
1096

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bechelli L. M., Garbajosa P. G., Gyi M. M., Uemura K., Sundaresan T., Martínez Domínguez V., Matejka M., Tamondong C., Quagliato R., Engler V. BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma. Bull World Health Organ. 1973;48(3):323–334. [PMC free article] [PubMed] [Google Scholar]
  2. Brown J. A., Stone M. M., Sutherland I. B.C.G. vaccination of children against leprosy in Uganda: results at end of second follow-up. Br Med J. 1968 Jan 6;1(5583):24–27. doi: 10.1136/bmj.1.5583.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Convit J., Ulrich M., Aranzazu N. Vaccination in leprosy--observations and interpretations. Int J Lepr Other Mycobact Dis. 1980 Mar;48(1):62–65. [PubMed] [Google Scholar]
  4. Kirchheimer W. F., Storrs E. E. Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. I. Report of lepromatoid leprosy in an experimentally infected armadillo. Int J Lepr Other Mycobact Dis. 1971 Jul-Sep;39(3):693–702. [PubMed] [Google Scholar]
  5. Shepard C. C., McRae D. H. Hereditary Characteristic that Varies Among Isolates of Mycobacterium leprae. Infect Immun. 1971 Jan;3(1):121–126. doi: 10.1128/iai.3.1.121-126.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Shepard C. C., Minagawa F., Van Landingham R., Walker L. L. Foot pad enlargement as a measure of induced immunity to Mycobacterium leprae. Int J Lepr Other Mycobact Dis. 1980 Dec;48(4):371–381. [PubMed] [Google Scholar]
  7. Shepard C. C., Van Landingham R., Walker L. L. Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions. Infect Immun. 1976 Oct;14(4):919–928. doi: 10.1128/iai.14.4.919-928.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Shepard C. C., Walker L. L., Van Landingham R. M. Immunity to Mycobacterium leprae infections induced in mice by BCG vaccination at different times before or after challenge. Infect Immun. 1978 Feb;19(2):391–394. doi: 10.1128/iai.19.2.391-394.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Shepard C. C., Walker L. L., Van Landingham R. M., Ye S. Z. Sensitization or tolerance to Mycobacterium leprae antigen by route of injection. Infect Immun. 1982 Nov;38(2):673–680. doi: 10.1128/iai.38.2.673-680.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Shepard C. C., Walker L. L., van Landingham R. Heat stability of Mycobacterium leprae immunogenicity. Infect Immun. 1978 Oct;22(1):87–93. doi: 10.1128/iai.22.1.87-93.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Shepard C. C., van Landingham R., Walker L. L. Searches among mycobacterial cultures for antileprosy vaccines. Infect Immun. 1980 Sep;29(3):1034–1039. doi: 10.1128/iai.29.3.1034-1039.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Stanley S. J., Howland C., Stone M. M., Sutherland I. BCG vaccination of children against leprosy in Uganda: final results. J Hyg (Lond) 1981 Oct;87(2):233–248. doi: 10.1017/s002217240006945x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES